Gainers
- Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.
- Seritage Growth Properties (NYSE: SRG) shares jumped 55.4% to $9.46 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale.
- Clovis Oncology, Inc. (NASDAQ: CLVS) climbed 37.4% to $2.98. Clovis Oncology said on July 1, it had a Type A meeting with the FDA.
- iRhythm Technologies, Inc. (NASDAQ: IRTC) shares jumped 22.3% to $140.89 after the company provided comment on the recently released Centers for Medicare and Medicaid Services Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2023.
- MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) rose 21.6% to $3.64 after gaining 9% on Thursday.
- The Vita Coco Company, Inc. (NASDAQ: COCO) gained 21.8% to $12.06 after B of A Securities upgraded the stock from Neutral to Buy and announced a $12 price target.
- Kura Sushi USA, Inc. (NASDAQ: KRUS) jumped 21.2% to $65.57 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
- Target (NYSE:TGT) Hospitality Corp. (NASDAQ: TH) gained 17.7% to $7.12 after the company raised its FY22 sales guidance above analyst estimates.
- Aprea Therapeutics, Inc. (NASDAQ: APRE) rose 16.9% to $0.9350. Wedbush initiated coverage on Aprea Therapeutics with an Outperform rating and announced a price target of $3.
- Recruiter.com Group, Inc. (NASDAQ: RCRT) gained 16.4% to $1.0950.
- Annexon, Inc. (NASDAQ: ANNX) jumped 16.6% to $4.63 after the company announced a $130 million private placement.
- Uxin Limited (NASDAQ: UXIN) gained 16.3% to $0.9306.
- Diebold Nixdorf, Incorporated (NYSE: DBD) rose 16.3% to $2.8950. Wedbush upgraded Diebold Nixdorf from Neutral to Outperform and announced a $5 price target.
- Alvotech (NASDAQ: ALVO) gained 15.7% to $8.28.
- Atreca, Inc. (NASDAQ: BCEL) gained 13.2% to $2.5590.
- Frequency Therapeutics, Inc. (NASDAQ: FREQ) jumped 13.1% to $1.7880.
- Acer Therapeutics Inc. (NASDAQ: ACER) gained 11.6% to $1.58 after the company and Relief Therapeutics announced the CNIPA issued a utility model patent covering dosage form claims related to ACER-001's polymer coated formulation.
- AppHarvest, Inc. (NASDAQ: APPH) jumped 11.5% to $4.6750.
- MRC Global Inc. (NYSE: MRC) gained 11.3% to $10.41 as the company raised FY22 sales forecast. Benchmark initiated coverage on MRC Global with a Buy rating and announced a price target of $14.
- Insignia Systems, Inc. (NASDAQ: ISIG) rose 11.1% to $9.00 after gaining around 6% on Thursday.
- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 10.4% to $0.2333 after gaining around 19% on Thursday. Allena Pharmaceuticals recently announced rescheduling of special meeting to approve reverse stock split.
- Mullen Automotive, Inc. (NASDAQ: MULN) jumped 10.3% to $1.18.
- Tyme Technologies, Inc. (NASDAQ: TYME) gained 10% to $0.2902. Syros Pharmaceuticals recently agreed to acquire TYME Technologies, including its pipeline assets and net cash, after accounting for wind-down and transaction expenses currently estimated to be approximately $60 million.
- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) gained 10% to $1.2650.
- Spirit Airlines, Inc. (NYSE: SAVE) rose 4.7% to $25.01. Spirit Airlines announced intention to adjourn special meeting of stockholders.
- Tesla, Inc. (NASDAQ: TSLA) gained 3.5% to $759.15. Tesla achieved its highest monthly sales of China-made vehicles in June since opening its Shanghai plant in 2019, Reuters reported. Tesla sold 78,906 China-made vehicles in June, including 968 for export, the China Passenger Car Association (CPCA) said.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
- Enjoy Technology, Inc. (NASDAQ: ENJY) dipped 36.5% to $0.2546. Enjoy Technology said that the company received a written notice from NASDAQ on delisting.
- Upstart (NASDAQ:UPST) Holdings, Inc. (NASDAQ: UPST) shares tumbled 20.2% to $26.92 after the company cut preliminary Q2 revenue outlook. Additionally, JMP Securities downgraded the stock from Market Outperform to Market Perform.
- AcelRx Pharmaceuticals, Inc (NASDAQ: ACRX) fell 15% to $0.30 after jumping 36% on Thursday.
- Envirotech Vehicles, Inc. (NASDAQ: EVTV) dropped 12.6% to $6.10.
- WD-40 Company (NASDAQ: WDFC) fell 12.3% to $179.51 after the company reported worse-than-expected Q3 EPS and sales results.
- SRAX, Inc. (NASDAQ: SRAX) declined 11% to $2.7317.
- Augmedix, Inc. (NASDAQ: AUGX) fell 10.6% to $1.68.
- Audacy, Inc. (NYSE: AUD) fell 10% to $0.8801 after Wells Fargo (NYSE:WFC) downgraded the stock from Equal-Weight to Underweight and lowered its price target from $2 to $0.
- Forward Pharma A/S (NASDAQ: FWP) declined 9.3% to $4.1701.
- SIGNA Sports United N.V. (NYSE: SSU) dropped 8.5% to $4.98.
- Empire State Realty OP, L.P. (NYSE: OGCP) fell 8% to $6.70.
- SIGA Technologies, Inc. (NASDAQ: SIGA) shares declined 7.6% to $12.83 following news the company's pox treatment received approval in the United Kingdom.
- American Rebel Holdings, Inc. (NASDAQ: AREB) shares fell 6.7% to $1.1101. American Rebel shares jumped 56% on Thursday after the company announced it has entered an agreement to acquire Champion Safe Company in a transaction valued at approximately $9.9 million.
- iHeartMedia, Inc. (NASDAQ: IHRT) was down, falling 5% to $7.00. Wells Fargo downgraded iHeartMedia from Overweight to Equal-Weight and lowered the price target from $23 to $9.
- Twitter, Inc. (NYSE: NYSE:TWTR) fell 3.8% to $37.32. Wedbush maintained Twitter with a Neutral and lowered the price target from $54 to $43.
- GameStop Corp . (NYSE: NYSE:GME) shares fell 3.3% to $130.71. GameStop fired its CFO, Mike Recupero and is also reportedly planning company-wide layoffs. The company also announced appointment of Diana Saadeh-Jajeh as CFO, effective immediately.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Read at Benzinga